Maynard Um
-
-
-
-
-
-
-
GeoVax discontinues COVID-19 vaccine to focus on mpox and cancer programs
-
-
-
-
-
-
-
GeoVax Labs announces 1-for-25 reverse stock split
-
-
-
-
-
-
-
Geovax Labs Inc. (GOVX) Misses Q3 EPS by 91c
-
-
-
-
-
-
-
Geovax Labs (GOVX) Announces Phase 2 Plans for Gedeptin® Cancer Therapy Following Clinical Advisory Committee Review
-
-
-
-
-
-
466,286 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


